Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease

American Journal of the Medical Sciences

Volumn 340, Issue 4, 2010, Pages 291-295

  Wang, Gui Rong ^a   Gao, Chen ^a   Shi, Qi ^a   Zhou, Wei ^a   Chen, Jian Ming ^a   Dong, Chen Fang ^a   Shi, Song ^a   Wang, Xin ^a   Wei, Yan ^a   Jiang, Hui Ying ^a   Han, Jun ^a   Dong, Xiao Ping ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

14 3 3; Cerebrospinal fluid; Creutzfeldt Jakob disease; ELISA; Tau

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; IMMUNOBLOTTING; INCIDENCE; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

14-3-3 PROTEINS; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHINA; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 77958005411     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181e92a1f     Document Type: Article

References (32)

1. Aguzzi A, Glatzel M, Montrasio F, et al. Interventional strategies against prion diseases. Nat Rev Neurosci 2001;2:745-749
2. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-815
3. Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995;5:459-466
4. Collins SJ, Lawson VA, Masters CL. Transmissible spongiform encephalopathies. Lancet 2004;363:51-61.
5. Meissner B, Körtner K, Bartl M, et al. Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology 2004;63:450-456
6. Collins S, Boyd A, Fletcher A, et al. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. J Clin Neurosci 2000;7:203-208
7. Lemstra AW, van Meegen MT, Vreyling JP, et al. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients. Neurology 2000;55:514-516
8. Selkoe DJ. The origins of Alzheimer disease. JAMA 2000;283: 1615-1617
9. Ghetti B, Dlouhy SR, Giaccone G, et al. Gerstmann-Straussler- Scheinker disease and the Indiana kindred. Brain Pathol 1995;5:61-75.
10. Ghetti B, Tagliavini F, Giaccone G, et al. Familial Gerstmann- Straussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol 1994;8:41-48
11. Goodall CA, Head MW, Everington D, et al. Raised CSF phospho- tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications. J Neurol Neurosurg Psychiatry 2006;77:89-91.
12. Otto M, Wiltfang J, Tumani H, et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997;225:210-212 (Pubitemid 27191632)
13. Green AJ, Thompson EJ, Stewart GE, et al. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt- Jakob disease. J Neurol Neurosurg Psychiatry 2001;70:744-748
14. Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, et al. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain 2006;129:2288-2296
15. Satoh K, Shirabe S, Eguchi H, et al. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt- Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol 2006;26:45-52.
16. Satoh K, Shirabe S, Tsujino A, et al. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 2007;24:207-212
17. Satoh K, Shirabe S, Eguchi H, et al. Chronological changes in MRI and CSF biochemical markers in Creutzfeldt-Jakob disease patients. Dement Geriatr Cogn Disord 2007;23:372-381
18. Collie DA, Sellar RJ, Zeidler M, et al. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001;56:726-739
19. Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004;56:702-708
20. Van Everbroeck B, Croes EA, Pals P, et al. Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob disease phenotype. Neurosci Lett 2001;313:69-72.
21. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40.
22. Praticò D, Clark CM, Lee VM, et al. Increased 8, 12-isoiPF2alpha- VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann Neurol 2000;48: 809-812
23. Van Everbroeck B, Quoilin S, Boons J, et al. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2003;74:1210-1214
24. Kapaki E, Kilidireas K, Paraskevas GP, et al. Highly increased CSF tau protein and decreasedβ-amyloid (1- 42) in sporadic CJD: a discrimination from Alzheimer's disease? J Neurol Neurosurg Psychiatry 2001;71:401-403
25. Hou X, Gao C, Zhang B, et al. Characteristics of polymorphism of 129th amino acid in PRNP among Han and Uighur Chinese [in Chinese]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2002;16:105-108
26. Ohkubo T, Sakasegawa Y, Asada T, et al. Absence of association between codon 129/219 polymorphisms of the prion protein gene and Alzheimer's disease in Japan. Ann Neurol 2003;53:409-412
27. Cuadrado-Corrales N, Jiménez-Huete A, Albo C, et al. Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD. BMC Neurol 2006;26:6-25.
28. Dougherty MK, Morrison DK. Unlocking the code of 14-3-3. J Cell Sci 2004;117:1875-1884
29. Sjögren M, Minthon L, Davidsson P, et al. CSF levels of tau, betaamyloid( 1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging. J Neural Transm 2000;107:563-579
30. Gómez-Tortosa E, Gonzalo I, Fanjul S, et al. Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease. Arch Neurol 2003;60:1218-1222 (Pubitemid 37099626)
31. Boesenberg-Grosse C, Schulz-Schaeffer WJ, Bodemer M, et al. Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD? BMC Neurol 2006;6:35.
32. Gloeckner SF, Meyne F, Wagner F, et al. Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia. J Alzheimers Dis 2008;14:17-25.